A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Rifamycin Impurity 22. Uses: For analytical and research use. Molecular formula: C37H43Br2NO12. Mole weight: 853.55. Catalog: APB09575.
Rifamycin Impurity 23
Rifamycin Impurity 23. Uses: For analytical and research use. Molecular formula: C37H44N2O14. Mole weight: 740.76. Catalog: APB09576.
Rifamycin Impurity 24
Rifamycin Impurity 24. Uses: For analytical and research use. Molecular formula: C37H42N2O14. Mole weight: 738.74. Catalog: APB09577.
Rifamycin Impurity 25
Rifamycin Impurity 25. Uses: For analytical and research use. CAS No. 13292-22-3. Molecular formula: C38H47NO13. Mole weight: 725.79. Catalog: APB13292223.
Rifamycin Impurity 4
Rifamycin Impurity 4. Uses: For analytical and research use. CAS No. 59264-04-9. Molecular formula: C37H45NO13. Mole weight: 711.76. Catalog: APB59264049.
Rifamycin Impurity 6
Rifamycin Impurity 6. Uses: For analytical and research use. Molecular formula: C37H45NO12. Mole weight: 695.76. Catalog: APB09580.
Rifamycin Impurity 7
Rifamycin Impurity 7. Uses: For analytical and research use. Molecular formula: C37H45NO12. Mole weight: 695.76. Catalog: APB09581.
Rifamycin Impurity 8
Rifamycin Impurity 8. Uses: For analytical and research use. Molecular formula: C34H41NO11. Mole weight: 639.70. Catalog: APB09582.
Rifamycin L
Rifamycin L is produced by the strain of Amycolatopsis mediterranei ME/83. It has the antibacterial action of rifamycin. Alternative Names: Rifamycin, 4-(hydroxyacetate). Grades: >98%. CAS No. 26117-02-2. Molecular formula: C39H49NO14. Mole weight: 755.80.
Rifamycin O
Rifaximin intermediate. Group: Biochemicals. Alternative Names: 4-O-(Carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-rifamycin γ-Lactone; NSC 182391. Grades: Highly Purified. CAS No. 14487-05-9. Pack Sizes: 100mg. US Biological Life Sciences.
Worldwide
Rifamycin Related Impurity 1
Rifamycin Related Impurity 1. Uses: For analytical and research use. Molecular formula: C50H62N4O13. Mole weight: 927.06. Catalog: APB09583.
Rifamycin S
Rifamycin S, a quinone, is an antibiotic against Gram-positive bacteria (including MRSA). Rifamycin S is the oxidized forms of a reversible oxidation-reduction system involving two electrons. Rifamycin S generates reactive oxygen species (ROS) and inhibits microsomal lipid peroxidation. Rifamycin S can be used for tuberculosis and leprosy[1][2][3]. Uses: Scientific research. Category: Signaling pathways. CAS No. 13553-79-2. Pack Sizes: 10 mM * 1 mL in DMSO; 250 mg; 500 mg; 1 g; 5 g; 10 g; 25 g; 50 g; 100 g. Product ID: HY-125365.
Rifamycin sodium
Rifamycin sodium (Rifamycin SV monosodium) is an orally active ansamycin antibiotic. Rifamycin sodium inhibits DNA-dependent RNA synthesis. Rifamycin sodium has antibacterial activity against Mycobacterium tuberculosis. Rifamycin sodium interferes with hepatic bile acid metabolism. Rifamycin sodium has anti-inflammatory effects. Rifamycin sodium can be used in the study of Mycobacterium tuberculosis, Bacteroides fragilis infection, and Lipopolysaccharide (HY-D1056B3)-induced inflammation[1][2][3][4][5][6][7][8][9][10][11]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Rifamycin SV sodium. CAS No. 14897-39-3. Pack Sizes: 10 mM * 1 mL in DMSO; 50 mg; 100 mg; 500 mg. Product ID: HY-B1907.
Rifamycin SV Sodium
Semi-synthetic antibiotic derived from Rifamycin S. Antibacterial. Potency >900 units (dry basis). Group: Biochemicals. Alternative Names: 5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-. Grades: Highly Purified. CAS No. 14897-39-3. Pack Sizes: 100mg. US Biological Life Sciences.
Worldwide
Rifamycin SV sodium salt
Rifamycin SV sodium salt. Alternative Names: Nsc133100. Grades: 95%. CAS No. 15105-92-7. Molecular formula: C37H47NO12.
Rifamycin W
Rifamycin W is originally isolated from Amycolatopsis mediterranei ME/83. It has anti-gram-positive bacterial activity. CAS No. 53904-81-7. Molecular formula: C35H45NO11. Mole weight: 655.73.
Rifapentine
Rifapentine (Priftin) is a semi-synthetic antibiotic compound used in the treatment of tuberculosis. Alternative Names: MDL473; MDL 473; MDL-473; DL 473; DL-473; DL473; R 773; R-773; R773. Grades: >98%. CAS No. 61379-65-5. Molecular formula: C47H64N4O12. Mole weight: 877.03.
Rifapentine
Semi-synthetic rifamycin. Antibacterial (tuberculostatic). Group: Biochemicals. Alternative Names: 3- [ [ (4-Cyclopentyl-1-piperazinyl) imino] methyl] rifamycin; Antibiotic DL 473IT; Cyclopentylrifampicin; DL 473; KTC 1; MDL 473; Prifitin; Priftin; R 77-3; Rifamycin AF/ACPP; Rifapentin. Grades: Highly Purified. CAS No. 61379-65-5. Pack Sizes: 50mg. US Biological Life Sciences.
Worldwide
Rifapentine
Rifapentine (DL 473) is an antibiotic used in tuberculosis research[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: DL 473; Cyclopentylrifampicin. CAS No. 61379-65-5. Pack Sizes: 10 mM * 1 mL in DMSO; 50 mg; 100 mg. Product ID: HY-B0269.
Rifapentine
Rifapentine is a cyclopentyl rifamycin derivative and an antimycobacterial antibiotic. Initially FDA-approved in 1998, it is supplied as film-coated tablets for oral administration. Rifapentine is a potent, bactericidal agent with a very broad spectrum of activity, but its clinical use is primarily restricted to the treatment of mycobacterial infections to prevent the rapid emergence of resistant bacteria. Applications: Rifapentine is indicated for the treatment of active pulmonary tuberculosis in patients 12 years and older, always as part of a combination regimen. it is also indicated for the treatment of latent tuberculosis infection in patients 2 years and older, specifically in a 12-week once-weekly regimen of directly observed therapy in combination with isoniazid (3hp). Category: Antibacterial apis. Synonyms: Priftin, Rifapentin, Cyclopentylrifampicin. CAS No. 61379-65-5. Product ID: API0232427. Molecular formula: C47H64N4O12. Mole weight: 877. EINECS: 262-743-9. InChIKey: WDZCUPBHRAEYDL-GZAUEHORSA-N.
Rifapentine hydrochloride
Rifapentine hydrochloride. Alternative Names: RIFAMYCIN, 3-[[(4-CYCLOPENTYL-1-PIPERAZINYL)IMINO]METHYL]-, MONOHYDROCHLORIDE;RIFAPENTINE HYDROCHLORIDE;3-[[(4-CYCLOPENTYL-1-PIPERAZINYL)-IMINO]METHYL]RIFAMYCIN/RIFAPENTINE HYDROCHLORIDE;RIFAPENTINE;3-[[(4-Cyclopentyl-1-piperazinyl)imino]methyl]rifamycin. CAS No. 127923-87-9. Product ID: ACM127923879. Molecular formula: C47H64N4O12?HCl. Mole weight: 913.5. Alfa Chemistry - ISO 9001:32057 Certified.
Rifapentine impurity 1
Rifapentine impurity 1. Uses: For analytical and research use. CAS No. 79039-56-8. Molecular formula: C45H62N4O11. Mole weight: 835.01. Catalog: APB79039568.
Rifapentine impurity 2
Rifapentine impurity 2. Uses: For analytical and research use. Molecular formula: C46H62N4O12. Mole weight: 863.02. Catalog: APB12241.
Rifapentine impurity 3
Rifapentine impurity 3. Uses: For analytical and research use. Molecular formula: C44H60N4O11. Mole weight: 820.98. Catalog: APB12240.
Rifapentine impurity 4
Rifapentine impurity 4. Uses: For analytical and research use. Molecular formula: C47H64N4O13. Mole weight: 893.04. Catalog: APB12244.
Rifapentine impurity 5
Rifapentine impurity 5. Uses: For analytical and research use. Molecular formula: C47H62N4O13. Mole weight: 891.03. Catalog: APB12242.
Rifapentine impurity 6
Rifapentine impurity 6. Uses: For analytical and research use. Molecular formula: C47H64N4O13. Mole weight: 893.04. Catalog: APB12245.
Rifapentine impurity 7
Rifapentine impurity 7. Uses: For analytical and research use. Molecular formula: C44H60N4O11. Mole weight: 820.98. Catalog: APB12243.
Rifasutenizol
Rifasutenizol (TNP-2198) is a dual-targeted antibacterial agent that has a good antibacterial effect on Helicobacter pylori infection. Rifasutenizol can be used in the study of microaerophilic and anaerobic bacterial infections[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: TNP-2198. CAS No. 1001314-13-1. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-144300.
Rifaximin
Rifaximin, a gastrointestinal-selective antibiotic, binds the β-subunit of bacterial DNA-dependent RNA polymerase, resulting in inhibition of bacterial RNA synthesis. Rifaximin susceptibility is higher against Gram-positive strains (MIC: 0.03-5 mg/ml) compared to Gram-negative bacteria (MIC: 8-50 mg/mL)[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 80621-81-4. Pack Sizes: 10 mM * 1 mL in DMSO; 500 mg; 1 g; 5 g. Product ID: HY-13234.
Rifaximin
Rifaximin is a semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. It also acts as a pregnane X receptor (PXR) agonist. It is approved for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. It is used to prevent and treat milk cow mastitis in the dry period caused by sensitive bacteria such as Staphylococcus aureus, Streptococcus and E. coli. Alternative Names: 4-Deoxy-4'-methylpyridol[1',2'-1,2]imidazo[5,4-c]rifamycin SV; Rifamycin L 105; Rifaxidin; L-105; Fatroximin; Normix; Rifacol; Xifaxan. Grades: >98%. CAS No. 80621-81-4. Molecular formula: C43H51N3O11. Mole weight: 785.88.
Rifaximin
1g Pack Size. Group: Antibiotics, Bioactive Small Molecules. Formula: C43H51N3O11. CAS No. 80621-81-4. Prepack ID 71861288-1g. Molecular Weight 785.88. See USA prepack pricing.
Rifaximin
5g Pack Size. Group: Antibiotics, Bioactive Small Molecules. Formula: C43H51N3O11. CAS No. 80621-81-4. Prepack ID 71861288-5g. Molecular Weight 785.88. See USA prepack pricing.
Rifaximin
Non-absorbable semisynthetic Rifamycin antibiotic. Group: Biochemicals. Alternative Names: 4-Deoxy-4-methylpyridol[1,2-1,2]imidazo[5,4-c]rifamycin SV; Rifamycin L 105; Rifaxidin; L-105; Fatroximin; Normix; Rifacol; Xifaxan. Grades: Highly Purified. CAS No. 80621-81-4. Pack Sizes: 10mg. US Biological Life Sciences.
Worldwide
Rifaximin-d6
Non-absorbable semisynthetic Rifamycin antibiotic. Group: Biochemicals. Alternative Names: 4-Deoxy-4-methylpyridol[1,2-1,2]imidazo[5,4-c]rifamycin SV-d6; Rifamycin L 105-d6; Rifaxidin-d6; L-105-d6; Fatroximin-d6; Normix-d6; Rifacol-d6; Xifaxan-d6. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences.
Worldwide
Rifaximin EP Impurity A
Rifaximin EP Impurity A is an impurity of Rifaximin. Rifaximin is a semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. It also acts as a pregnane X receptor (PXR) agonist. It is approved for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. Alternative Names: 4-Methyl-2-pyridinamine; 2-Amino-4-picoline; Aminopicoline; Ascensil; NSC 1490; NSC 176165; NSC 6972. CAS No. 695-34-1. Molecular formula: C6H8N2. Mole weight: 108.14.
Rifaximin EP Impurity A
Rifaximin EP Impurity A. Uses: For analytical and research use. CAS No. 695-34-1. Molecular formula: C6H8N2. Mole weight: 108.14. Catalog: APB695341.
Rifaximin EP Impurity B
Rifaximin EP Impurity B is an impurity of Rifaximin. Rifaximin is a semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. It also acts as a pregnane X receptor (PXR) agonist. It is approved for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. Uses: A rifamycin (r508200) derivative as antibacterial agent. Alternative Names: Rifamycin B; Nancimycin; 4-O-(Carboxymethyl)rifamycin; 4-O-(Carboxymethyl)rifamycin; [(1,2-Dihydro-5,6,17,19,21-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-9-yl)oxy]acetic Acid 21-Acetate. CAS No. 13929-35-6. Molecular formula: C39H49NO14. Mole weight: 755.80.
Rifaximin EP Impurity B (Rifamycin EP Impurity A)
Rifaximin EP Impurity B (Rifamycin EP Impurity A). Uses: For analytical and research use. CAS No. 13929-35-6. Molecular formula: C39H49NO14. Mole weight: 755.81. Catalog: APB13929356.
Rifaximin EP Impurity C
Rifaximin EP Impurity C is an antibacterial drug which functions by inhibiting bacterial RNA polymerase (RNAP), is an impurity of Rifaximin. It also has anti-gram-positive bacterial and mycobacterium activities. Uses: Anti-bacterial agents. Alternative Names: Rifamycin SV; Rifocin; Rifamicine SV; (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-21-(Acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione. Grades: >95%. CAS No. 6998-60-3. Molecular formula: C37H47NO12. Mole weight: 697.77.
Rifaximin EP Impurity C (Rifamycin)
Rifaximin EP Impurity C (Rifamycin). Uses: For analytical and research use. CAS No. 6998-60-3. Molecular formula: C37H47NO12. Mole weight: 697.78. Catalog: APB6998603.
Rifaximin EP Impurity C Sodium Salt (Rifamycin Sodium)
Rifaximin EP Impurity C Sodium Salt (Rifamycin Sodium). Uses: For analytical and research use. CAS No. 14897-39-3. Molecular formula: C37H46NNaO12. Mole weight: 719.76. Catalog: APB14897393.
Rifaximin EP Impurity D
Rifaximin EP Impurity D. Uses: For analytical and research use. Molecular formula: C43H49N3O12. Mole weight: 799.87. Catalog: APB10841.
Rifaximin EP Impurity D
Rifaximin EP Impurity D is an impurity of Rifaximin. Rifaximin is a semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. It also acts as a pregnane X receptor (PXR) agonist. It is approved for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. Alternative Names: Rifaximin Y. Grades: >95%. Molecular formula: C43H49N3O12. Mole weight: 799.86.
Rifaximin EP Impurity E
Rifaximin EP Impurity E is an impurity of Rifaximin. Rifaximin is a semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. It also acts as a pregnane X receptor (PXR) agonist. It is approved for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. Alternative Names: Rifamycin S; 5,17,19,21-Tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,6,9,11(2H)-tetrone 21-Acetate; 1,4-Dideoxy-1,4-dihydro-1,4-dioxorifamycin. Grades: 98%. CAS No. 13553-79-2. Molecular formula: C37H45NO12. Mole weight: 695.75.
Rifaximin EP Impurity E (Rifamycin EP Impurity B)
Rifaximin EP Impurity E (Rifamycin EP Impurity B). Uses: For analytical and research use. CAS No. 13553-79-2. Molecular formula: C37H45NO12. Mole weight: 695.76. Catalog: APB13553792.
Rifaximin EP Impurity F
Rifaximin EP Impurity F is an intermediate of Rifaximin. Rifaximin is a semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. It also acts as a pregnane X receptor (PXR) agonist. It is approved for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. Uses: Rifaximin intermediate. Alternative Names: Rifamycin O; 4-O-(Carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-rifamycin γ-Lactone. Grades: 95%. CAS No. 14487-05-9. Molecular formula: C39H47NO14. Mole weight: 753.79.
Rifaximin EP Impurity F (Rifamycin EP Impurity C)
Rifaximin EP Impurity F (Rifamycin EP Impurity C). Uses: For analytical and research use. CAS No. 14487-05-9. Molecular formula: C39H47NO14. Mole weight: 753.8. Catalog: APB14487059.
Rifaximin EP Impurity G
Rifaximin EP Impurity G. Uses: For analytical and research use. CAS No. 80621-76-7. Molecular formula: C43H49N3O11. Mole weight: 783.88. Catalog: APB80621767.
Rifaximin EP Impurity G
Rifaximin EP Impurity G is an intermediate of Rifaximin. Rifaximin is a semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. It also acts as a pregnane X receptor (PXR) agonist. It is approved for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. Alternative Names: Dehydro Rifaximin; 6-o,14-Didehydrorifaximin; [2S-(2R*,16Z,18E,20R*,21R*,22S*,23S*,24S*,25R*,26S*,27R*,28E)]-25-(Acetyloxy)-5,21,23-trihydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-6H-27-(epoxypentadeca[1,11,13]trienonitrilo)benzofuro[4,5-e]pyrido[1,2-a]benzimidazole-1,6,15(2H)-trione. Grades: 90%. CAS No. 80621-76-7. Molecular formula: C43H49N3O11. Mole weight: 783.86.
Rifaximin EP Impurity H
Rifaximin EP Impurity H is an intermediate of Rifaximin. Rifaximin is a semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. It also acts as a pregnane X receptor (PXR) agonist. It is approved for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. Alternative Names: 16-Desmethyl-16-(hydroxymethyl)rifaximin; (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-25-(Acetyloxy)-5,6,21,23-tetrahydroxy-16-(hydroxymethyl)-27-methoxy-2,4,11,20,22,24,26-heptamethyl-2,7-(epoxypentadeca(1,11,13)trienimino)benzofuro(4,5-E)pyrido(1,2-a)benzimidazole-1,15(2H)-dione. Grades: 90%. CAS No. 1210022-90-4. Molecular formula: C43H51N3O12. Mole weight: 801.88.
Rifaximin EP Impurity H
Rifaximin EP Impurity H. Uses: For analytical and research use. CAS No. 1210022-90-4. Molecular formula: C43H51N3O12. Mole weight: 801.89. Catalog: APB1210022904.
Rifaximin Impurity 1
Rifaximin Impurity 1. Uses: For analytical and research use. CAS No. 1351775-04-6. Molecular formula: C43H49N3O11. Mole weight: 783.88. Catalog: APB1351775046.
Rifaximin Impurity 2
Rifaximin Impurity 2. Uses: For analytical and research use. CAS No. 1351775-03-5. Molecular formula: C43H49N3O11. Mole weight: 783.88. Catalog: APB1351775035.
Rifaximin Impurity 3
Rifaximin Impurity 3. Uses: For analytical and research use. CAS No. 1262992-43-7. Molecular formula: C43H45D6N3O11. Mole weight: 791.93. Catalog: APB1262992437.
Rifaximin Impurity 7
Rifaximin Impurity 7. Uses: For analytical and research use. Molecular formula: C39H45NO15. Mole weight: 767.78. Catalog: APB10842.
Rifaximin Impurity 8
Rifaximin Impurity 8. Uses: For analytical and research use. CAS No. 80621-88-1. Molecular formula: C41H49N3O10. Mole weight: 743.85. Catalog: APB80621881.
RIG012
RIG012 is a potent RIG-I inhibitor with an IC50 of 0.71 μM using the NADH-coupled ATPase assay. RIG012 inhibits IFN-β and ISG hRsad2 expression[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2642218-43-5. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-147124.
Rig I
One unit of the enzyme is the amount required to hydrolyze 1 μg of Ad2 DNA in 1 hour at 37°C in a total reaction volume of 50 μl. Applications: After 3-fold overdigestion with enzyme > 95% of ad2 dna fragments can be ligated with t4 dna ligase and recut. Group: Restriction Enzymes. Purity: 100U; 500U. GGCCGG↑CC CC↓GGCCGG. Activity: 2000u.a./ml. Appearance: 10 X SE-buffer RigI, BSA. Storage: -20°C. Storage at -70°C is recommended for periods longer than 7 days. Form: Liquid. Source: Rhizobium yangligense. Pack: 10 mM Tris-HCl (pH 7.5); 100 mM KCl; 0.1 mM EDTA; 7 mM 2-mercaptoethanol; 200 μg/ml BSA; 50% glycerol. Cat No: ET-1165RE.
Rigid Extrusion PVC Resin
This is a medium-low molecular weight PVC designed primarily for rigid extrusion applications. Alternative Names: Paste poly(vinyl chloride) resins.
Rigid Polyimide Foam
Rigid Polyimide Foam.
Rigosertib
Rigosertib (ON-01910) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3 kinase/Akt pathway, promots the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle[1][2]. Rigosertib is a selective and non-ATP-competitive inhibitor of PLK1 with an IC50 of 9 nM[3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: ON-01910. CAS No. 592542-59-1. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-12037A.
Rigosertib sodium
Rigosertib sodium (ON-01910 sodium) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3K/Akt pathway, promotes the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle[1][2]. Rigosertib sodium is a selective and non-ATP-competitive inhibitor of PLK1 with an IC50 of 9 nM[3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: ON-01910 sodium. CAS No. 592542-60-4. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-12037.
Rigosertib sodium
Rigosertib (ON-01910 sodium salt), a synthetic benzyl styryl sulfone analogue with potential antineoplastic activity, is a non-ATP-competitive inhibitor of PLK1 (IC50=9 nM), inducing selective G2/M arrest followed by apoptosis in a variety of tumor cells while causing reversible cell arrest at the G1 and G2 stage without apoptosis in normal cells. This agent may exhibit synergistic antitumor activity in combination with other chemotherapeutic agents. Plk1, named after the polo gene of Drosophila melanogaster, is a serine / threonine protein kinase involved in regulating mitotic spindle function in a non-ATP competitive manner. Alternative Names: Glycine, N-[2-methoxy-5-[[[(1E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl]methyl]phenyl]-, monosodium salt (9CI); (E)-2,4,6-Trimethoxystyryl 3-[(carboxymethyl)amino]-4-methoxybenzyl sulfone sodium salt; Novonex; ON 01910 sodium; ON01910 sodium; ON-01910 sodium; ON 01910 sodium salt; Rigosertib sodium. CAS No. 1225497-78-8. Molecular formula: C21H24NNaO8S. Mole weight: 473.47.
RIKKUNSHITO(Liu Jun Zi Tang) 5:1
RIKKUNSHITO(Liu Jun Zi Tang) 5:1.
CA, FL & NJ
Rilapladib
Rilapladib is the third genomics-derived small molecule drug as a lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor which is an enzyme associated with the formation of atherosclerotic plaques. Uses: 1-alkyl-2-acetylglycerophosphocholine esterase inhibitors. Alternative Names: GSK 659032; GSK659032; GSK-659032; SB-659032; SB659032; SB 659032; GTPL7376; GTPL-7376; GTPL 7376; D05728. Grades: ≥98%. CAS No. 412950-08-4. Molecular formula: C40H38F5N3O3S. Mole weight: 735.81.
Rilapladib
Rilapladib (SB 659032) is a selective Lp-PLA2 (lipoprotein-associated phospholipase A2) inhibitor with an IC50 of 230 pM[1]. Rilapladib (SB 659032) is also a PAFR (Platelet Activating Factor Receptor) antagonist[2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: SB 659032. CAS No. 412950-08-4. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-102004.
Rilematovir
Rilematovir (JNJ-678) is a novel fusion protein inhibitor. Rilematovir has the potential for respiratory syncytial virus (RSV) research. Uses: Scientific research. Category: Signaling pathways. Alternative Names: JNJ-678; JNJ-53718678. CAS No. 1383450-81-4. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-112180.
Riliprubart
Riliprubart (SAR 445088) is an anti-C1s humanized IgG4 monoclonal antibody that inhibits activated C1s in the proximal portion of the classical complement system. Riliprubart selectively inhibits activated C1s and prevents the enzymatic action of C1 on its substrates C4 and C2, thus inhibiting the formation of the classical pathway C3 convertase, C4b2a. Riliprubart can be used to study complement-mediated diseases such as systemic lupus erythematosus. Recommend Isotype Controls: Human IgG4 (S228P) kappa, Isotype Control (HY-P99003)[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: SAR 445088. CAS No. 2756228-76-7. Pack Sizes: 1 mg; 2 mg; 5 mg; 10 mg. Product ID: HY-P990091.
Rilmazafone hydrochloride
Rilmazafone hydrochloride (450191S) is a benzodiazepine (omega) ligand[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: 450191S. CAS No. 85815-37-8. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-U00228.